Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diasporal Pro DEPOT is a nutritional supplement developed to support sleep quality and muscle relaxation, particularly in individuals experiencing sleep disturbances. It features a combination of magnesium and melatonin delivered via a specialized biphasic depot formulation. Melatonin is a chronobiotic hormone that regulates the sleep-wake cycle, helping to reduce the time required to fall asleep. Magnesium is an essential mineral that contributes to normal muscle function and the reduction of tiredness and fatigue by modulating neuromuscular excitability. The 2-phase tablet is designed to provide an immediate release of melatonin to aid sleep onset, followed by a sustained release of both magnesium and additional melatonin to support sleep maintenance throughout the night. It is marketed as an over-the-counter (OTC) product by ERWO Pharma and Protina Pharmazeutische GmbH.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diasporal Pro DEPOT.